SourceClinicalTrials.govClinical Study of Local and Systemic Biological Impact of GLP1/GIP-Receptor Agonists in Patients With Breast Cancer: The CLARA Trial
- Publisher
- ClinicalTrials.gov
- Date
- Jul 7, 2026
- Trust tier
- clinical-trials
- License
- ClinicalTrials.gov public registry record
SourceElsevier BVA data-driven modeling framework for mapping genotypes to synthetic microbial community functions
- Publisher
- Elsevier BV
- Date
- Jul 1, 2026
- Trust tier
- openalex
- License
- Not specified
SourceEuropean Organization for Nuclear ResearchAdaptive Bio-Intelligence Scaffold (ABIS) Theory A Computational and Theoretical Framework for Self-Learning Tissue Engineering Systems
- Publisher
- European Organization for Nuclear Research
- Date
- Jul 3, 2026
- Trust tier
- openalex
- License
- cc-by
SourceNature PortfolioEngineering drug-responsive replication machinery for precise control of self-amplifying RNA
- Publisher
- Nature Portfolio
- Date
- Jun 23, 2026
- Trust tier
- openalex
- License
- cc-by
SourceElsevier BVHigh-throughput DNA engineering by mating bacteria
- Publisher
- Elsevier BV
- Date
- Jul 1, 2026
- Trust tier
- openalex
- License
- Not specified
SourceSpringer Science and Business Media LLCEndogenous constitutive promoters with a broad range of transcriptional activities for plant synthetic biology
- Publisher
- Springer Science and Business Media LLC
- Date
- Jun 22, 2026
- Trust tier
- crossref
- License
- https://www.springernature.com/gp/researchers/text-and-data-mining
SourceNature PortfolioA guide to CAR T cell therapies: development, current status and future prospects
- Publisher
- Nature Portfolio
- Date
- Jul 2, 2026
- Trust tier
- openalex
- License
- Not specified
SourceClinicalTrials.govCD19-Directed CAR-T Cell Therapy in Refractory Systemic Lupus Erythematosus
- Publisher
- ClinicalTrials.gov
- Date
- Jun 22, 2026
- Trust tier
- clinical-trials
- License
- ClinicalTrials.gov public registry record
SourceElsevier BVProgrammable regenerative tissues: Converging mammalian synthetic biology and tissue engineering
- Publisher
- Elsevier BV
- Date
- Jul 1, 2026
- Trust tier
- crossref
- License
- https://www.elsevier.com/tdm/userlicense/1.0/
SourceJournal of High School ScienceSynthetic antigen-augmented SynNotch CAR T Cell therapy for Glioblastoma: a conceptual design review
- Publisher
- Journal of High School Science
- Date
- Jul 5, 2026
- Trust tier
- openalex
- License
- cc-by-nc-sa
SourceOxford University Press (OUP)Horseradish peroxidase as an electrochemical reporter protein for cell-free biosensors
- Publisher
- Oxford University Press (OUP)
- Date
- Jul 7, 2026
- Trust tier
- crossref
- License
- https://creativecommons.org/licenses/by/4.0/
SourceMultidisciplinary Digital Publishing InstituteThe Mevalonate Pathway: Innovations, Applications, and Challenges in Biotechnology with Emphasis on Fungal Biology
- Publisher
- Multidisciplinary Digital Publishing Institute
- Date
- Jul 7, 2026
- Trust tier
- openalex
- License
- cc-by
SourceClinicalTrials.govAssessment of T-cell Response and In-vitro Proof-of-concept of T-cell Engineering in Chronic ESKD Patients.
- Publisher
- ClinicalTrials.gov
- Date
- Jun 25, 2026
- Trust tier
- clinical-trials
- License
- ClinicalTrials.gov public registry record
SourceClinicalTrials.govVaccine Responses in Patients With B Cell Malignancies
- Publisher
- ClinicalTrials.gov
- Date
- Jul 7, 2026
- Trust tier
- clinical-trials
- License
- ClinicalTrials.gov public registry record
SourceOxford University Press (OUP)Better synthetic biology outcomes through balanced push-pull engineering
- Publisher
- Oxford University Press (OUP)
- Date
- Jun 26, 2026
- Trust tier
- crossref
- License
- https://creativecommons.org/licenses/by/4.0/
SourceNature PortfolioClocked stepping of an artificial protein walker along a DNA track
- Publisher
- Nature Portfolio
- Date
- Jul 1, 2026
- Trust tier
- openalex
- License
- cc-by
SourceEuropean Organization for Nuclear ResearchInterdisciplinary Insights Into Modern Drug Delivery Platforms: Engineering, Biology, And Medicine
- Publisher
- European Organization for Nuclear Research
- Date
- Jun 22, 2026
- Trust tier
- openalex
- License
- cc-by
SourceSpringer Science and Business Media LLCLentiviral single-cell MPRA of synthetic enhancers reveals motif affinity-based encoding of cell state specificity
- Publisher
- Springer Science and Business Media LLC
- Date
- Jul 14, 2026
- Trust tier
- crossref
- License
- https://creativecommons.org/licenses/by/4.0
SourceAmerican Chemical Society (ACS)Machine Learning for Microbial Cell Factories: Pathway Design, Enzyme Engineering, and Metabolic Regulation
- Publisher
- American Chemical Society (ACS)
- Date
- Jun 26, 2026
- Trust tier
- crossref
- License
- https://doi.org/10.15223/policy-029
SourcePharaonic Journal of ScienceSynthetic Organelles: Programmable Bio-Organic Compartments for Next-Generation Biocatalysis and Therapeutics
- Publisher
- Pharaonic Journal of Science
- Date
- Jun 21, 2026
- Trust tier
- openalex
- License
- cc-by-sa
SourceNews UKGenerative AI for controllable protein sequence design: A survey
- Publisher
- News UK
- Date
- Jul 3, 2026
- Trust tier
- openalex
- License
- cc-by-nc-nd
SourceElsevier BVS-layers as natural building blocks for nanobiotechnology and synthetic biology
- Publisher
- Elsevier BV
- Date
- Jul 3, 2026
- Trust tier
- openalex
- License
- Not specified
SourceAmerican Chemical SocietyMicrofluidics-Based Engineering of Molecular Self-Assembly and Manufacturing for Artificial Cell Systems
- Publisher
- American Chemical Society
- Date
- Jun 26, 2026
- Trust tier
- openalex
- License
- Not specified
SourceFrontiers Media SASynthetic biology and genome engineering in support of human, agricultural, and environmental security
- Publisher
- Frontiers Media SA
- Date
- Jul 6, 2026
- Trust tier
- crossref
- License
- https://creativecommons.org/licenses/by/4.0/
SourceClinicalTrials.govRecombinant Erwinia Asparaginase and Venetoclax in Combination With Blinatumomab for the Treatment of Relapsed or Refractory CD19 Positive B-cell Acute Lymphoblastic Leukemia
- Publisher
- ClinicalTrials.gov
- Date
- Jul 14, 2026
- Trust tier
- clinical-trials
- License
- ClinicalTrials.gov public registry record
SourceClinicalTrials.govTesting a New Immune Cell Therapy, GD2-Targeted Modified T-cells (GD2CART), in Children, Adolescents, and Young Adults With Relapsed/Refractory Osteosarcoma and Neuroblastoma, The GD2-CAR PERSIST Trial
- Publisher
- ClinicalTrials.gov
- Date
- Jul 8, 2026
- Trust tier
- clinical-trials
- License
- ClinicalTrials.gov public registry record
SourceEuropean Organization for Nuclear ResearchInterdisciplinary Insights Into Modern Drug Delivery Platforms: Engineering, Biology, And Medicine
- Publisher
- European Organization for Nuclear Research
- Date
- Jun 22, 2026
- Trust tier
- openalex
- License
- cc-by
SourceSpringer Science and Business Media LLCL-NAME promotes foam cell formation and synthetic phenotype marker changes in vascular smooth muscle cells independent of hemodynamic effects
- Publisher
- Springer Science and Business Media LLC
- Date
- Jul 13, 2026
- Trust tier
- crossref
- License
- https://creativecommons.org/licenses/by-nc-nd/4.0
SourceElsevier BVMachine learning-guided sustainable human type I collagen fragment production in engineered microbial cells for tissue engineering
- Publisher
- Elsevier BV
- Date
- Jul 8, 2026
- Trust tier
- openalex
- License
- Not specified
SourceMacquarie UniversityA Synthetic Biology approach for investigating principles underlying the functional-dependent organization of genomes
- Publisher
- Macquarie University
- Date
- Jul 16, 2026
- Trust tier
- openalex
- License
- Not specified
SourceOpenAlex indexed sourceBridging Biology and Industry
- Publisher
- OpenAlex indexed source
- Date
- Jul 8, 2026
- Trust tier
- openalex
- License
- Not specified
SourceEuropean Organization for Nuclear ResearchThe Synthetic Cell and the Question of Biological Information: From Engineering to Ontological Ground
- Publisher
- European Organization for Nuclear Research
- Date
- Jul 6, 2026
- Trust tier
- openalex
- License
- cc-by
SourceCold Spring Harbor LaboratoryEngineering the bacterial cellulose-forming surface as a programmable protein recruitment interface
- Publisher
- Cold Spring Harbor Laboratory
- Date
- Jul 14, 2026
- Trust tier
- openalex
- License
- cc-by
SourceMultidisciplinary Digital Publishing InstituteFunctional Engineering of Bioactive Peptides: Chemical Modifications and Synthetic Biology Approaches
- Publisher
- Multidisciplinary Digital Publishing Institute
- Date
- Jul 1, 2026
- Trust tier
- openalex
- License
- cc-by
SourceFrontiers MediaRethinking governance of synthetic cells
- Publisher
- Frontiers Media
- Date
- Jul 9, 2026
- Trust tier
- openalex
- License
- cc-by
SourceAmerican Chemical Society (ACS)Special Issue on Mammalian Cell Synthetic Biology
- Publisher
- American Chemical Society (ACS)
- Date
- Jun 19, 2026
- Trust tier
- crossref
- License
- https://doi.org/10.15223/policy-001
SourceFrontiers Media SAEditorial: Metabolic engineering and synthetic biology for sustainable microbial cell factories
- Publisher
- Frontiers Media SA
- Date
- Jul 8, 2026
- Trust tier
- crossref
- License
- https://creativecommons.org/licenses/by/4.0/
SourceCold Spring Harbor LaboratoryProgramming Metabolic Dependency in Synthetic Cells Under Resource Scarcity
- Publisher
- Cold Spring Harbor Laboratory
- Date
- Jul 3, 2026
- Trust tier
- openalex
- License
- cc-by-nc-nd
SourceThe Company of BiologistsSynthetic developmental engineering of human liver organogenesis
- Publisher
- The Company of Biologists
- Date
- Jul 1, 2026
- Trust tier
- openalex
- License
- Not specified
SourceEuropean Organization for Nuclear ResearchThe Synthetic Cell and the Question of Biological Information: From Engineering to Ontological Ground
- Publisher
- European Organization for Nuclear Research
- Date
- Jul 6, 2026
- Trust tier
- openalex
- License
- cc-by
SourceEuropean Organization for Nuclear ResearchAdaptive Bio-Intelligence Scaffold (ABIS) Theory A Computational and Theoretical Framework for Self-Learning Tissue Engineering Systems
- Publisher
- European Organization for Nuclear Research
- Date
- Jul 3, 2026
- Trust tier
- openalex
- License
- cc-by
SourceElsevier BVTetrahymena as a model organism for cilia research
- Publisher
- Elsevier BV
- Date
- Jul 1, 2026
- Trust tier
- crossref
- License
- https://www.elsevier.com/tdm/userlicense/1.0/
SourceClinicalTrials.govSafety, Tolerability and Preliminary Efficacy of NEUK203-13 in Refractory Neuroendocrine Tumor Patients
- Publisher
- ClinicalTrials.gov
- Date
- Jun 25, 2026
- Trust tier
- clinical-trials
- License
- ClinicalTrials.gov public registry record
SourceClinicalTrials.govNatural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
- Publisher
- ClinicalTrials.gov
- Date
- Jul 14, 2026
- Trust tier
- clinical-trials
- License
- ClinicalTrials.gov public registry record
SourceMacquarie UniversityA Synthetic Biology approach for investigating principles underlying the functional-dependent organization of genomes
- Publisher
- Macquarie University
- Date
- Jul 16, 2026
- Trust tier
- openalex
- License
- Not specified
SourceClinicalTrials.govAdministration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell Transplantation
- Publisher
- ClinicalTrials.gov
- Date
- Jul 17, 2026
- Trust tier
- clinical-trials
- License
- ClinicalTrials.gov public registry record